Filing Details
- Accession Number:
- 0001209191-18-011018
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-16 18:25:19
- Reporting Period:
- 2018-02-16
- Accepted Time:
- 2018-02-16 18:25:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1326732 | Xencor Inc | XNCR | Pharmaceutical Preparations (2834) | 201622502 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1591213 | A Paul Foster | C/O Xencor, Inc. 111 West Lemon Avenue Monrovia CA 91016 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-02-16 | 5,000 | $0.59 | 7,419 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-02-16 | 5,000 | $25.01 | 2,419 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2018-02-16 | 5,000 | $0.00 | 5,000 | $0.59 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
48,064 | 2022-09-25 | No | 4 | M | Direct |
Footnotes
- Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted November 23, 2015.
- The stock option is fully vested.